Personal information

No personal information available

Activities

Works (1)

Tislelizumab and Radiation Therapy in Low-Risk Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Phase II Study Protocol

Future Oncology
2024-02 | Journal article
Contributors: Jia-Ying Li; Shu-Nan Qi; Chen Hu; Xin Liu; Yong Yang; Tao Wu; Rong Zheng; Xiao-Li Feng; Xiao-Guang Ni; Feng-Yan Jin et al.
Source: check_circle
Crossref